PUBLICATIONS · 18626004
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 Sep 20
- First author
- Robinson KS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Robinson KS
- type
- Author
- name
- Williams ME
- type
- Author
- name
- van der Jagt RH
- type
- Author
- name
- Cohen P
- type
- Author
- name
- Herst JA
- type
- Author
- name
- Tulpule A
- type
- Author
- name
- Schwartzberg LS
- type
- Author
- name
- Lemieux B
- type
- Author
- name
- Cheson BD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Robinson KS
- type
- Author
- name
- Williams ME
- type
- Author
- name
- van der Jagt RH
- type
- Author
- name
- Cohen P
- type
- Author
- name
- Herst JA
- type
- Author
- name
- Tulpule A
- type
- Author
- name
- Schwartzberg LS
- type
- Author
- name
- Lemieux B
- type
- Author
- name
- Cheson BD
- type
- Author
- bibliography ids
- nci-bib-fa1edc9b9d707b126d604eaa
- book metadata
- content sha256
- 6956e82332866f14dcf4f099d10bc9e2b9e858e2af19f99b47e7db61cc5e3662
- document type
- citation
- dois
- 10.1200/JCO.2008.17.0001
- electronic publication date
- display
- 2008 Jul 14
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18626004
- immutable id
- pubmed:18626004@6956e82332866f14dcf4f099d10bc9e2b9e858e2af19f99b47e7db61cc5e3662
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 27
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4473-9
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18626004
- provenance
- batch id
- 6281e3e555c9a831cffc
- provider
- NCBI PubMed ESummary
- record sha256
- 8bd15112d0711faf9fe031f5922eadcc4017e118bd38848ae263cadd9e35e61b
- response sha256
- 0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
- retrieved at
- 2026-09-09T23:46:21.772457+00:00
- publication date
- display
- 2008 Sep 20
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle